Manufacturing and Production

Showing 15 posts of 5862 posts found.

zarxio

Sandoz launches first US biosimilar

September 3, 2015 Manufacturing and Production, Sales and Marketing Amgen, Neupogen, Novartis, Sandoz, Zarxio, biosimilar, biosimilars, filgrastim

Sandoz, the generics arm of the pharma giants Novartis, has become the first company to launch a biosimilar product in …
dun___bradstreet_4efa511357b57

Shire appoints Sara Mathew to board of directors

September 2, 2015 Manufacturing and Production, Research and Development, Sales and Marketing Sara Mathew, Shire

Shire has appointed Sara Mathew to its board of directors as a non-executive director.Mathew will also be a member of …
scales

Standardising the pharma benefit-risk assessment process

September 1, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, FDA, benefit-risk analysis, pharmacoepidemiology, pharmacovigilance

Over the past decade, pharmaceutical companies and regulatory agencies have been reviewing the benefit-risk assessment of medicines with a view …
Alexion sign

Alexion scores double EU approval

September 1, 2015 Manufacturing and Production, Sales and Marketing Alexion, EC, European Commission, Kanuma, Strensiq, asfotase alfa, sebelipase alfa, ultra rare disease, ultra-rare disease

Two treatments developed by ultra-rare disease specialists Alexion Pharmaceuticals are now approved for use in Europe. The European Commission approved …

Bristol-Myers Squibb makes big pharma deals

September 1, 2015 Manufacturing and Production BMS, Bristol-Myers Squibb, PRM-151, Promedior, QIMR, fibrosis, idiopathic pulmonary fibrosis, immuno-oncology, myelofibrosis

Bristol-Myers Squibb is flexing its muscles in respiratory disease, by signing a deal to acquire the exclusive right to acquire …
FDA sign

FDA issues gliptin joint pain warning

September 1, 2015 Manufacturing and Production DPP-4 inhibitors, ESC, FDA, TECOS, adverse effects, drug safety, gliptins, safety alert, safety warning

The FDA has issued a safety alert, warning of joint pain caused by the gliptins, a common class of drugs …
st_judes_ensite_precision_mapping_module

Abbott to table $25bn bid for medical device maker St Jude?

August 27, 2015 Manufacturing and Production, Sales and Marketing Abbott Laboratories, mergers and acquisitions, st jude medical

Abbott Laboratories is said to be preparing a $25 billion takeover bid for medical device maker St Jude Medical.  Illinois-based Abbott …
artist's impression

Novo Nordisk plans $2bn expansion of production facilities

August 26, 2015 Manufacturing and Production, Research and Development Novo Nordisk, manufacturing

Novo Nordisk will invest an estimated $2 billion over the next five years in new production facilities in the US, …
Abasaglar

Lilly and Boehringer launch biosimilar insulin in the UK

August 26, 2015 Manufacturing and Production, Research and Development, Sales and Marketing Boehringer, Boehringer Ingelheim, Eli Lilly, Lantus, abasaglar, basal insulin, biosimilar, biosimilars, diabetes, insuling glargine, lilly

Lilly and Boehringer Ingelheim have launched their biosimilar insulin, called abasaglar, for the UK market. Abasaglar will now challenge the …
swine flu virus

TSRI and Janssen close in on universal flu vaccine

August 25, 2015 Manufacturing and Production Janssen, Vaccine, flu, immunology, universal flu vaccine

Scientists from Janssen and The Scripps Research Institute (TSRI) have found a way to induce antibodies to fight a wide …
Allergan

Allergan recalls eye drugs after complaints of blurred vision

August 25, 2015 Manufacturing and Production Allergan, manufacturing, product recalls, production, recalls

Allergan has issued a recall for batches of eye ointments sold in the US, after customers complained of foreign bodies …
Takeda oncology

Takeda in Velcade patent blow

August 25, 2015 Manufacturing and Production Actavis, Sandoz, Takeda, Velcade, bortezomib, ixazomib

Takeda has lost a court case contesting the patent for its blockbuster multiple myeloma drug Velcade, in a decision that …
sean_bohen

AZ appoints Genentech’s Sean Bohen as chief medical officer

August 25, 2015 Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, Briggs Morrison, Sean Bohen

AstraZeneca has appointed Dr Sean Bohen as executive vice president of global medicines development and chief medical officer.Dr Bohen will …
Pharma pill manufacturing

FDA hits Mylan’s Indian plants with warning letter

August 20, 2015 Manufacturing and Production Contamination, FDA, Mylan, Pfizer, manufacturing, production

The FDA has served Mylan with a warning letter citing contamination at three of its manufacturing facilities in India. Inspections …
Advanced melanoma

Novartis and Merck skin cancer drugs move through pipeline

August 20, 2015 Manufacturing and Production, Research and Development, Sales and Marketing Merck, Novartis, Odomzo, basal cell carcinoma, keytruda, melanoma, pembrolizumab, skin cancer, sonidegib

Both Novartis and Merck have hit regulatory milestones with their skin cancer drugs in the EU and the US. Novartis’ …
The Gateway to Local Adoption Series

Latest content